TWI400094B - Skin external preparations - Google Patents
Skin external preparations Download PDFInfo
- Publication number
- TWI400094B TWI400094B TW098133946A TW98133946A TWI400094B TW I400094 B TWI400094 B TW I400094B TW 098133946 A TW098133946 A TW 098133946A TW 98133946 A TW98133946 A TW 98133946A TW I400094 B TWI400094 B TW I400094B
- Authority
- TW
- Taiwan
- Prior art keywords
- fluorenyl group
- carbon atoms
- skin
- general formula
- derivative
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 34
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 29
- 206010000496 acne Diseases 0.000 claims description 29
- 230000002087 whitening effect Effects 0.000 claims description 29
- SFUCGABQOMYVJW-MRVPVSSYSA-N 4-[(3r)-3-hydroxybutyl]phenol Chemical class C[C@@H](O)CCC1=CC=C(O)C=C1 SFUCGABQOMYVJW-MRVPVSSYSA-N 0.000 claims description 26
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims description 23
- -1 toluene alcohol derivative Chemical class 0.000 claims description 22
- 239000002537 cosmetic Substances 0.000 claims description 20
- 230000002421 anti-septic effect Effects 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 239000004875 Anti-Odour Agent Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 4
- 239000003899 bactericide agent Substances 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 description 28
- 238000012360 testing method Methods 0.000 description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 230000000844 anti-bacterial effect Effects 0.000 description 27
- 230000000052 comparative effect Effects 0.000 description 27
- 238000004519 manufacturing process Methods 0.000 description 27
- 238000000034 method Methods 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- 239000012043 crude product Substances 0.000 description 16
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 14
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 14
- SFUCGABQOMYVJW-UHFFFAOYSA-N rac-rhododendrol Natural products CC(O)CCC1=CC=C(O)C=C1 SFUCGABQOMYVJW-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 235000002597 Solanum melongena Nutrition 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 244000061458 Solanum melongena Species 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 230000002265 prevention Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 239000002884 skin cream Substances 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 241000186427 Cutibacterium acnes Species 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 239000000058 anti acne agent Substances 0.000 description 5
- 229940124340 antiacne agent Drugs 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229960005323 phenoxyethanol Drugs 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 4
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000000707 wrist Anatomy 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000186245 Corynebacterium xerosis Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 241000208422 Rhododendron Species 0.000 description 3
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 229940055019 propionibacterium acne Drugs 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 3
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- NQWRBKVDLUSZBH-UHFFFAOYSA-N [4-(3-hydroxybutyl)phenyl] acetate Chemical compound CC(O)CCC1=CC=C(OC(C)=O)C=C1 NQWRBKVDLUSZBH-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229960001755 resorcinol Drugs 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical class [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OYAQUBKYAKSHOA-UHFFFAOYSA-N 2-(2-hydroxy-5-propylphenyl)-4-propylphenol Chemical group CCCC1=CC=C(O)C(C=2C(=CC=C(CCC)C=2)O)=C1 OYAQUBKYAKSHOA-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- SIAARBXVWRWGGR-UHFFFAOYSA-N 4-(4-hydroxyphenyl)butan-2-yl acetate Chemical compound CC(=O)OC(C)CCC1=CC=C(O)C=C1 SIAARBXVWRWGGR-UHFFFAOYSA-N 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 244000274847 Betula papyrifera Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- YWMKFSXKVWHBGC-UHFFFAOYSA-N C(=CC)OC(CCC1=CC=C(C=C1)C(C(=O)O)C)C Chemical compound C(=CC)OC(CCC1=CC=C(C=C1)C(C(=O)O)C)C YWMKFSXKVWHBGC-UHFFFAOYSA-N 0.000 description 1
- FLGLIDWQEYMOGA-UHFFFAOYSA-N C(CCCCCCC)(=O)OC1=CC=C(C=C1)CCC(C)OCCCCCCCC Chemical compound C(CCCCCCC)(=O)OC1=CC=C(C=C1)CCC(C)OCCCCCCCC FLGLIDWQEYMOGA-UHFFFAOYSA-N 0.000 description 1
- NKQQLVFXLYUYGW-UHFFFAOYSA-N C(CCCCCCCCCCCCCCC)(=O)OC(C)CCC1=CC=C(C=C1)O Chemical compound C(CCCCCCCCCCCCCCC)(=O)OC(C)CCC1=CC=C(C=C1)O NKQQLVFXLYUYGW-UHFFFAOYSA-N 0.000 description 1
- ZFEXHCIEELCKDK-UHFFFAOYSA-N CCCCC(CC(CCCC)C(=O)O)C1=CC=C(C=C1)O Chemical compound CCCCC(CC(CCCC)C(=O)O)C1=CC=C(C=C1)O ZFEXHCIEELCKDK-UHFFFAOYSA-N 0.000 description 1
- JXXPXJIRCIQTOX-UHFFFAOYSA-N CCOC(C)CCC1=CC=C(C=C1)CC(=O)O Chemical compound CCOC(C)CCC1=CC=C(C=C1)CC(=O)O JXXPXJIRCIQTOX-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical class CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000128206 Pyracantha coccinea Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001335 aliphatic alkanes Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical compound [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- MWEQTWJABOLLOS-UHFFFAOYSA-L disodium;[[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;trihydrate Chemical compound O.O.O.[Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP([O-])(=O)OP(O)([O-])=O)C(O)C1O MWEQTWJABOLLOS-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 150000002028 dodecanols Chemical class 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 208000002557 hidradenitis Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229960000990 monobenzone Drugs 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- VWMVAQHMFFZQGD-UHFFFAOYSA-N p-Hydroxybenzyl acetone Natural products CC(=O)CC1=CC=C(O)C=C1 VWMVAQHMFFZQGD-UHFFFAOYSA-N 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical group C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- WEIATHGPGPOEDH-UHFFFAOYSA-N phenyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC=CC=C1 WEIATHGPGPOEDH-UHFFFAOYSA-N 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000036619 pore blockages Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 238000006177 thiolation reaction Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- CAYKLJBSARHIDI-UHFFFAOYSA-K trichloroalumane;hydrate Chemical compound O.Cl[Al](Cl)Cl CAYKLJBSARHIDI-UHFFFAOYSA-K 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- PBSRSWFGYPZDAU-FFIPNUABSA-H trimagnesium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2h-furan-4-yl] phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] PBSRSWFGYPZDAU-FFIPNUABSA-H 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
- A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
本發明係關於一種皮膚外用劑。
黑斑、雀斑係因黑色素之生成與排泄的平衡崩壞,於表皮細胞中過剩地蓄積黑色素所致。此等的原因在於發炎、荷爾蒙平衡、遺傳性要因等各種因素,但亦受到紫外線影響而助長。進行緩和所增加之色素沉澱者為美白劑。其中,作為應用於防止皮膚黑化或黑斑、雀斑,並保持原有淨白肌膚的美白化妝料,已知有麴酸、熊果素、氫醌單苄醚、過氧化氫等。然而,若調配此等美白劑,雖具有使色黑肌膚淡色化的效果,但作為美白化妝料時仍無法得到充分滿足的效果,再者,其並無抑制因紫外線所造成之發炎的效果,於安全面方面大多亦殘存著問題。又,作為抑制因紫外線所造成之發炎的美白劑,已知有維他命C及其衍生物。然而,此等在美白效果之程度、及製劑中之穩定性方面尚無法獲得滿足。
另外,習知化妝品或醫藥外用品、醫藥品中,頻繁地使用對羥苯甲酸甲酯、對羥苯甲酸乙酯、對羥苯甲酸丙酯、對羥苯甲酸丁酯等之對羥苯甲酸類作為防腐殺菌劑,而近年來以低刺激性或敏感肌膚用等為訴求的化妝料上市,期望有對羥苯甲酸類之使用量的減低或替代方法等。作為其手法,提案有植物萃取物之調配或1,2-戊二醇或1,2-己二醇等之烷二醇之調配等各種方法(專利文獻1~5)。然而,由調配於化妝品等中時之製劑質地或對穩定性之影響或味道等之嗜好性的觀點而言,此等成分存在有其使用量受限的課題。
另外,痤瘡(尋常性痤瘡)之病狀,大致分為1)非發炎性皮疹之面皰、2)紅色丘疹等之發炎性丘疹、3)瘢痕、4)發炎後色素沉澱。其治療係配合病狀,將1)局部外用療法、2)全身內服療法、3)理學性療法之3種治療法予以單獨或組合實施。其中,局部外用療法被認為係對瘢痕以外之症狀有效的治療方法,而迄今已開發出調配了各種有效成分的外用劑(非專利文獻1)。痤瘡之發症機序大致分為二個階段。第一階段為面皰形成,第二階段為發炎引發。面皰係因過剩之皮脂分泌與毛孔部之角質化亢進,而堵塞毛孔且皮脂貯留於毛囊內所形成。面皰係皮膚常在菌之厭氣性細菌之痤瘡桿菌(propionibacterium acnes)所適合的生長環境,故在面皰中,該菌數增加並產生細胞外發炎誘發物質,故引發紅色丘疹等之發炎性丘疹(非專利文獻2)。作為此等般之痤瘡的預防‧改善對策,已知有防止成為毛孔堵塞原因之皮脂(三甘油酯)或角質肥厚的洗臉、維他命B6等之抗脂漏劑的使用、以間苯二酚或水楊酸等進行之不需要之角質的早期剝離、以阻礙P.acnes之生長的異丙基甲基酚般之高殺菌效果的抗菌性物質所進行的惡化防止、抗發炎劑之使用等(非專利文獻3)。又,對於發炎後之色素沉澱,以維他命C(抗壞血酸)衍生物所進行之局部外用療法正受到矚目(非專利文獻1),再者,尚報告有藉由組合酪胺酸酶活性抑制劑與抗菌或抗痤瘡劑,以預防或改善痤瘡痕跡之黑斑的手法(專利文獻6、7)。
另外,人體體臭中,具有獨特臭味的腋臭,其原因在於由腋下部之頂泌汗腺所分泌的糖蛋白、脂質等被皮膚細菌所產生之酵素分解,而產生揮發性、異臭性之脂肪酸等所致(非專利文獻4)。作為產生特別強烈而不佳之腋臭的原因細菌,可舉例如結膜乾燥症棒狀桿菌(Corynebacterium xerosis),由於其屬於好脂性菌,故在皮脂腺與汗腺較多之腋部被檢測到。作為對屬於棒狀桿菌屬之細菌具有效果的抗菌劑、腋臭用之組成物,已提案有習知被使用作為食品‧化妝品之防腐劑或保存劑的脂肪酸之蔗糖酯(專利文獻8)、屬於除菌‧殺菌成分之三氯沙及異丙基甲基酚(專利文獻9)、亦可食用的金萱草之花蕾萃取物(專利文獻10)、用於提高抗菌活性之烷二醇、溶菌酶(專利文獻11)。為了防止腋臭,必需有制汗與殺菌之2個機能。習知,作為制汗之一例子,係使用羥基氯化鋁(鋁氯化水合物)般之鋁鹽作為收斂劑。又,作為殺菌之一例子,係使用殺藻胺等具有廣泛殺菌活性的物質作為抗菌劑(非專利文獻3)。然而,目前尚未發現具有充分效果的抗臭活性劑。
如上述般,過去雖已進行了許多以美白、防腐抗菌、痤瘡預防‧改善及抗臭為目的的皮膚外用劑的研討,但均難以同時兼顧到充分之效果與製劑之課題。
另一方面,杜鵑醇(Rhododendrol)及其一部分之衍生物,係具有優越之美白作用,並對特異之菌顯示抗菌效果,故被提案應用於皮膚外用劑(專利文獻12~14)。又,已報告有含有杜鵑醇之苯丁酸類係對數種菌顯示抗菌作用(非專利文獻5)。
[專利文獻1]日本專利特開平8-73364號公報
[專利文獻2]日本專利特開平8-73368號公報
[專利文獻3]日本專利特開平10-182333號公報
[專利文獻4]日本專利特開平10-203955號公報
[專利文獻5]日本專利特開平11-322591號公報
[專利文獻6]日本專利特開2002-145802號公報
[專利文獻7]日本專利第2883368號公報
[專利文獻8]日本專利特開2002-255775號公報
[專利文獻9]日本專利特開2006-96719號公報
[專利文獻10]日本專利特開2007-1948號公報
[專利文獻11]日本專利特開2007-145750號公報
[專利文獻12]日本專利第3340935號公報
[專利文獻13]日本專利特開2008-7432號公報
[專利文獻14]國際公開第09-084200號說明書
[非專利文獻1]FRAGRANCE JOURNAL,2007年,第35卷,第5號,p.12-17
[非專利文獻2]COSMETIC STAGE,2007年,第1卷,第5號,p.23-27
[非專利文獻3]FRAGRANCE JOURNAL,2003年,第31卷,第3號,p.23-28
[非專利文獻4]今門純久著「汗的全部 頂泌汗腺疾病」Mon Book Derma,2007年3月,p.45-47
[非專利文獻5]P. Srinivasa Reddy,Kaiser Jamil等人,Pharmaceutical Biology,39,236-238,2001
然而,此等杜鵑醇及其衍生物係有對於被廣泛使用作為化妝料基劑之低極性溶媒的溶解性問題,而難以應用至各種化妝料製劑。又,基於相同理由,現狀係能充分發揮該等有效性之製劑的研討受到限制。
本發明之課題在於提供一種提升對於低極性溶媒之溶解性、可容易應用於各種化妝料製劑的新穎之杜鵑醇衍生物,以及含有其之美白效果、防腐抗菌效果、痤瘡預防‧改善效果以及抗臭效果均優越的皮膚外用劑。
本發明者等人為了解決上述情況而進行潛心研究,結果發現,下述一般式(1)所示之杜鵑醇之丁基上之羥基被醯基化的新穎杜鵑醇衍生物,係相較於杜鵑醇或酚性羥基被醯基化的杜鵑醇衍生物,對於被廣泛使用作為化妝料基劑之低極性溶媒的溶解性更優越。結果,其對於各種化妝料製劑的應用變得容易,再者,亦確認到其可充分揮發美白效果、對細菌之抗菌效果、對痤瘡原因菌之P. acnes之增殖抑制效果、痤瘡痕跡之預防‧改善效果以及對產生不佳腋臭之原因細菌:結膜乾燥症棒狀桿菌(Corynebacterium xerosis)之殺菌效果,遂完成本發明。
亦即,本發明係提供一種皮膚外用劑,其含有下述一般式(1)所示之杜鵑醇衍生物。
(式中,R1
表示碳數2~20之醯基,R2
表示氫原子或碳數2~20之醯基。)
另外,本發明係提供一種下述一般式(1b)所示之杜鵑醇衍生物。
(式中,R1b
及R2b
分別表示碳數3~20之醯基。)
另外,本發明係提供一種美白劑、防腐抗菌劑、抗痤瘡劑及抗臭劑,係以下述一般式(1a)所示之杜鵑醇衍生物作為有效成分。
(式中,R1a
表示碳數2~4之醯基。)
另外,本發明係提供一種上述一般式(1a)所示之杜鵑醇衍生物之用於製造美白劑、防腐抗菌劑、抗痤瘡劑及抗臭劑的用途。
另外,本發明係提供一種美白方法、防腐抗菌方法、痤瘡治療法或抗臭方法,其特徵為應用上述一般式(1a)所示之杜鵑醇衍生物。
本發明之杜鵑醇衍生醇係對低極性溶媒的溶解性高,容易應用至各種化妝料製劑,且可提供美白效果、防腐抗菌效果、痤瘡預防‧改善效果均優越的皮膚外用劑。
以下詳細敘述本發明之實施形態。
本發明所使用之杜鵑醇衍生物,係上述一般式(1)所示之化合物,式(1)中,R1
表示碳數2~20之醯基,R2
表示氫原子或碳數2~20之醯基。R1
及R2
可同時為相同碳數之醯基,亦可分別為不同碳數之醯基。R1
及R2
之醯基可為飽和或不飽和,又,亦可具有胺基等之官能基。其中,更佳為飽和之烷醯基。具體可舉例如乙醯基、丙醯基、丁醯基、異丁醯基、戊醯基、己醯基、辛醯基、月桂醯基、軟脂醯基、硬脂醯基等。其中,較佳為碳數2~18之烷醯基、更佳為碳數2~8之烷醯基,在屬於碳數2~4之乙醯基、丙醯基、丁醯基、異丁醯基的情況,係容易應用於化妝料製劑而特佳。
一般式(1)所示之杜鵑醇衍生物中,下述一般式(1b)所示之化合物為新穎化合物。
(式中,R1b
及R2b
分別表示碳數3~20之醯基。)
又,一般式(1)中,由對美白劑、防腐抗菌劑、抗痤瘡劑及抗臭劑之應用性的觀點而言,較佳係R1
為碳數2~8之醯基(尤其是碳數2~4之醯基)、R2
為氫原子或碳數2~8之醯基(尤其是氫原子或碳數2~4之醯基)的化合物,特佳為下述一般式(1a)所示之化合物。
(式中,R1a
表示碳數2~4之醯基。)
本發明中所使用之杜鵑醇衍生物之製造方法,係使用藉公知合成方法所得之杜鵑醇、或由馬斯槭或白樺等之含有杜鵑醇之植物的萃取物所分離精製者作為起始原料,利用公知之醯基化反應,則可製造。例如有於吡啶溶媒中,使杜鵑醇與酸氯化物或酸酐反應的方法等。又,亦可將馬斯槭等之植物萃取物以適當方法予以醯基化後,將目標之杜鵑醇衍生物進行分離精製而得。
藉上述方法等所得之杜鵑醇衍生物雖存在光學異構物,但(+)物、(-)物可單獨使用,亦可使用其等之混合物。
一般式(1)所示之杜鵑醇衍生物,係如後述實施例所示般具有美白作用、防腐抗菌作用、痤瘡預防改善作用、抗臭作用,且對低極性溶媒之溶解性優越,故可作為美白劑、美白化妝料、抗痤瘡劑、痤瘡肌膚用皮膚外用劑、防腐抗菌劑、抗臭劑、抗臭用皮膚外用劑。
另外,本發明所使用之杜鵑醇衍生物,係於上述一般式(1)所示之杜鵑醇衍生物中,可單獨使用任1種,亦可將此等之2種以上作成混合物而使用。
本發明之杜鵑醇衍生物之含量,係視調配目的、調配對象而無法一概規定,通常係以皮膚外用劑之總量為基準,可設為0.00001質量%~10.0質量%、較佳0.001質量%~5.0質量%、更佳0.01質量%~3.0質量%。
本發明之皮膚外用劑係除了本發明之杜鵑醇衍生物之外,可將己知美白劑的氫醌、熊果素、土耳其鞣酸、維他命C及其衍生物(例如抗壞血酸糖苷、抗壞血酸磷酸酯鈉、抗壞血酸硫酸酯2鈉、抗壞血酸磷酸酯鎂等),聯苯衍生物(例如去氫二甲酚、2,2’-二羥基-5,5’-二丙基聯苯等),以及日本專利第3340935號記載之烯酮素(raspberry ketone)、己醯基烯酮素、辛醯基烯酮素、杜鵑醇、4-(3-羥基丁基)苯基乙酸酯等之黑色素生成抑制劑,火棘萃取物、山藥萃取物、岩白菜萃取物、洋甘菊萃取物、腺苷5’-1磷酸及其鹽、亞麻油酸衍生物、傳明酸及傳明酸鹽、傳明酸衍生物等之美白劑予以適當組合使用。
另外,若與皮膚外用劑等一般所使用之屬於防腐劑的醇類、苯氧基乙醇、二丙二醇或丁二醇等之多元醇、烷二醇、乙二胺四乙酸鈉等之嵌合劑併用,則藉由相乘效果,可提升防腐殺菌效果。尤其是若併用苯氧基乙醇,則於防腐殺菌效果方面為更佳。
另外,本發明之皮膚外用劑係除了上述之外,可在不損及本發明目的之範圍內,適當調配玻尿酸、多元醇、糖醇等之保濕劑,焦油系色素、氧化鐵等之著色顏料,對羥苯甲酸酯等之防腐劑,脂肪酸皂、鯨蠟基硫酸鈉等之陰離子性界面活性劑,聚氧乙烯烷基醚、聚氧乙烯脂肪酸酯、聚氧乙烯多元醇脂肪酸酯、聚氧乙烯硬化蓖麻油、多元醇脂肪酸酯、聚甘油脂肪酸酯等之非離子性界面活性劑,四烷基銨鹽等之陽離子性界面活性劑、甜菜型、磺酸基甜菜型、磺酸基胺基酸型、N-硬脂醯基-L-麩醯胺酸鈉等之兩離子性界面活性劑,卵磷脂、溶血磷脂醯膽等之天然系界面活性劑,明膠、酪素、澱粉、阿拉伯膠、刺梧桐膠、關亞膠、刺槐豆膠、黃蓍樹膠、榅桲籽、果膠、紅藻膠、精胺酸鈉等之天然高分子,甲基纖維素、羥乙基纖維素、羥丙基纖維素、羧基甲基纖維素鈉、乙基纖維素等之半合成高分子,聚乙烯醇、聚乙烯甲基醚及共聚物、聚乙烯吡咯啶酮、聚丙烯酸鈉、羧基乙烯基聚合物、聚環氧乙烷聚合物等之合成高分子,三仙膠等之增黏劑,氧化鈦等之顏料,二丁基羥基甲苯等之抗氧化劑等。
本發明之皮膚外用劑的形態,係由於使杜鵑醇衍生物溶解於低極性之溶媒中,故無特別限制,可作成軟膏、乳膏、洗劑、防曬劑、美容液、乳液、面膜、入浴劑等之形態。
以下根據製造例、試驗例及實施例詳細說明本發明,但本發明並不限定於此等。又,以下記載之杜鵑醇係使用將市售之4-(對羥基苯基)-2-丁醇(烯酮素)以氫化硼鈉藉常法予以還原而製造者。又,各化合物之構造係藉由NMR測定(JEOL JNM-LA400(日本電子公司製),1
H;400MHz、13
C;100MHz、CDCl3
)而確認。
將杜鵑醇(5.0g)置入200mL茄型燒瓶中,溶解於吡啶(1mL)中,加入醋酸酐(8.0g)使其反應。4小時後,依常法進行後處理,將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為醋酸乙酯/正己烷(1/5)而精製,以無色透明之油狀物質得到目標之杜鵑醇衍生物(5.4g)。將13
C-NMR之結果示於以下。
13
C-NMR(100MHz,CDCl3
)δ(ppm):170.8、169.7、148.9、139.1、129.2、121.4、70.4、37.4、31.1、21.2、21.0、19.9
將杜鵑醇(5.0g)置入200mL茄型燒瓶中,依序加入吡啶(1.0mL)、醋酸酐(8.0g),4小時後,依常法進行後處理,得到粗製生成物。將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為醋酸乙酯/正己烷(1/5)而予以分離、精製。將所得精製物(3.0g)置入200mL茄型燒瓶中,加入80vol%甲醇水溶液(120mL)並攪拌。再加入醋酸銨(7.5g),於40℃反應48小時後,依常法進行後處理,得到粗製生成物。將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為醋酸乙酯/正己烷(1/4)而精製,以無色油狀物質形態得到目標之杜鵑醇衍生物(1.1g)。將13
C-NMR之結果示於以下。
13
C-NMR(100MHz,CDCl3
)δ(ppm):171.7、154.2、133.1、129.3、115.3、70.9、37.6、30.7、21.2、19.8
將杜鵑醇(2.5g)置入200mL茄型燒瓶中,溶解於吡啶(5mL)及四氫呋喃(50mL)中,於冰冷下滴下丙醯氯(5.0g),24小時後,依常法進行後處理,將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為醋酸乙酯/正己烷(1/5)而精製,以無色透明之油狀物質形態得到目標之杜鵑醇衍生物(3.3g)。將13
C-NMR之結果示於以下。
13
C-NMR(100MHz,CDCl3
)δ(ppm):173.9、172.8、148.8、138.8、129.0、121.2、69.9、37.3、30.9、27.5、27.4、19.7、8.9、8.7
將杜鵑醇(5.0g)置入200mL茄型燒瓶中,溶解於吡啶(7.5mL)及四氫呋喃(92.5mL)中,於冰冷下一邊攪拌一邊滴下辛醯氯(12.5g),4小時後,依常法進行後處理,將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為正己烷而精製,以無色透明之油狀物質形態得到目標之杜鵑醇衍生物(11.3g)。將13
C-NMR之結果示於以下。
13
C-NMR(100MHz,CDCl3
)δ(ppm):173.5、172.5、148.9、139.0、129.2、121.4、70.1、37.6、34.7、34.4、31.7、31.7、31.2、29.1、29.0、28.9、28.9、25.1、25.0、22.6、22.6、20.1、14.0、14.0
將杜鵑醇(5.0g)置入200mL茄型燒瓶中,溶解於吡啶(7.5mL)及四氫呋喃(92.5mL)中,於冰冷下一邊攪拌一邊滴下辛醯氯(12.5g),4小時後,依常法進行後處理,得到粗製生成物。將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為正己烷而分離、精製。將所得精製物(5.0g)置入200mL茄型燒瓶中,加入80vol%乙腈水溶液(100mL)並攪拌。再加入醋酸銨(6.0g),於50℃反應96小時後,依常法進行後處理,得到粗製生成物。將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為醋酸乙酯/正己烷(1/4)而精製,以無色油狀物質形態得到目標之杜鵑醇衍生物(1.3g)。將13
C-NMR之結果示於以下。
13
C-NMR(100MHz,CDCl3
)δ(ppm):174.0、154.0、133.5、129.4、115.3、70.3、37.8、34.7、31.6、30.8、29.0、28.8、25.0、22.5、19.9、13.9
將杜鵑醇(1.7g)置入200mL茄型燒瓶中,溶解於吡啶(2mL)及四氫呋喃(50mL)中,於冰冷下滴下軟脂醯氯(9.5g),24小時後,依常法進行後處理,將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為正己烷而予以分離、精製,以白色結晶形態得到目標之杜鵑醇衍生物(3.7g)。將13
C-NMR之結果示於以下。
13
C-NMR(100MHz,CDCl3
)δ(ppm):173.1、172.0、148.8、138.8、128.9、121.3、69.9、37.5、34.4、34.2、31.8、31.1、29.6、29.6、29.5、29.4、29.4、29.3、29.2、29.2、29.1、29.0、29.0、25.0、24.8、22.6、19.9、14.0
將杜鵑醇(1.7g)置入200mL茄型燒瓶中,溶解於吡啶(2mL)及四氫呋喃(50mL)中,於冰冷下滴下軟脂醯氯(9.5g),24小時後,依常法進行後處理。將所得之粗製生成物供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為正己烷而精製。將所得精製物(1.0g)置入200mL茄型燒瓶中,使其溶解於THF100mL中,滴下1NNaOH水溶液。以TLC確認反應物消失後,依常法進行後處理。將粗製生成物溶解於0.1N KOH水溶液中,於室溫攪拌30分鐘後,以醋酸乙酯萃取。將醋酸乙酯層濃縮後,供於矽膠管柱層析法(矽膠60N:100-210μm;關東化學公司製),將移動相設為醋酸乙酯/正己烷(1/9)而精製,以白色結晶形態得到目標之杜鵑醇衍生物(0.5g)。將13
C-NMR之結果示於以下。
13
C-NMR(100MHz,CDCl3
)δ(ppm):174.0、154.2、133.8、129.6、115.5、70.6、38.0、35.0、32.1、31.1、29.9、29.9、29.8、29.7、29.6、29.5、29.4、25.3、22.9、20.2、14.3
使用上述製造例1~4所得之杜鵑醇衍生物,進行以下所示之溶解性試驗。使用杜鵑醇及4-(3-羥基丁基)苯基乙酸酯作為比較對照之比較例1及2。
於製造例1~4及比較例1~2之各化合物(0.1g)中,加入下表1所示之溶媒(1mL),於40℃加溫10分鐘後,回復為室溫。分取各溶液之上清液,將以醋酸乙酯稀釋50倍者作為試料,藉氣體層析法評價各溶解性。評價係依10~100mg/mL之範圍進行。
分析條件:
管柱:DB-1(Agilent Technologies公司製,30m×0.25mm×0.25mm)
烘爐:130℃5分鐘,以10℃/分鐘自130℃升溫至260℃
檢測器:FID、250℃
試料導入:Split、250℃、Split racio 1:50、1μL
將結果示於下表1。
由表1可知,本發明之杜鵑醇衍生物係相較於比較例1(杜鵑醇)、比較例2(4-(3-羥基丁基)苯基乙酸酯),對於低極性溶媒之溶解性提升。又,由製造例2與比較例2之比較可確認,在對杜鵑醇加成醯基時,視該加成位置而溶解性不同,本發明物較比較例2格外地提升了溶解性。又,製造例1~4之對DPG或乙醇的溶解性,確認到保持為與比較例1、2相同,可確認本發明物對通用化妝品基劑具有寬廣的溶解範圍。
使用由上述製造例2所得之杜鵑醇衍生物,進行下示之抗菌力試驗。使用杜鵑醇(比較例1)及苯氧基乙醇(比較例3)作為比較對象。
根據日本化學療法學會標準法之洋菜平板稀釋法,藉由測定表2所示之各種微生物之最小發育阻止濃度(MIC,單位μg/mL)而評價抗菌性。亦即,調製以成為625~10000μg/mL之範圍內濃度之方式添加了評價試料(製造例2及比較例1、3)的培養基,使用此等培養基評價表2所示之各種微生物的增殖性。培養基及培養條件中,關於(3)之Candida albicans係使用葡萄糖‧果膠洋菜培養基,於25℃好氣條件下培養72小時,關於其他則使用大豆酪素消化液洋菜培養基,於30℃好氣條件下培養48小時後,確認其等之增殖性。
將其結果示於表3。
由表3之結果可確認到,製造例2之杜鵑醇衍生物係相較於比較例2之杜鵑醇,所有菌株之MIC值較低,故為具有非常高抗菌活性之優越的防腐殺菌劑。又,相較於比較例3之苯氧基乙醇,顯示同程度之MIC值,故顯示其為與一般防腐抗菌劑所知之苯氧基乙醇同等有效的防腐抗菌劑。
使用由上述製造例2所得之杜鵑醇衍生物,進行以下所示之抗菌力試驗。使用杜鵑醇(比較例1)及間苯二酚(比較例4)作為比較對象。
進行與試驗例2相同之試驗。亦即,調製以成為625~10000μg/mL之範圍內濃度之方式添加了評價試料(製造例2及比較例1、4)的培養基,使用此等培養基評價Propionibacterium acnes的增殖性。使用腦心浸出物洋菜培養基,於37℃厭氣條件下培養72小時後,確認其等之增殖性。
結果示於表4。
由表4之結果可知,製造例2之杜鵑醇衍生物係較比較例1及比較例4,對Propionibacterium acnes具有非常高之抗菌力。
依照下表5所示之配方,調製痤瘡肌膚用皮膚外用劑(化妝水),依以下所示之評價法評價其抗痤瘡效果。
將於顏面上具有痤瘡之18歲至30歲的成人10名(男性5名、女性5名)設為1群而評價各評價試驗。早晚一日2次,以相同洗臉皂洗臉後,盲目地使用各評價試料。將使用開始前與使用1周後之顏面痤瘡狀態以與目視相同之照片攝影進行比較,針對症狀變化以「改善」、「稍有改善」、「無變化」、「稍有惡化」、「惡化」之5階段進行評價。
讓上述之「痤瘡改善效果」之評價者繼續連續使用樣本,針對使用開始四周後之顏面痤瘡痕跡的狀態,以與目視相同之相片攝影,比較1周後之狀態,針對其變化以「改善」、「稍有改善」、「無變化」、「稍有惡化」、「惡化」之5階段進行評價。
結果示於表5。
由表5之結果可知,相較於比較例5,實施例1之痤瘡改善效果及痤瘡痕跡改善效果較優越。
使用上述製造例2所得之杜鵑醇衍生物,進行下示之抗菌力試驗。使用杜鵑醇(比較例1)作為比較對象。
進行與試驗例2相同之試驗。亦即,調製以成為625~10000μg/mL之範圍內濃度之方式添加了評價試料(製造例2及比較例1)的培養基,使用此等培養基評價Corynebacterium xerosis的增殖性。培養基及培養條件,係使用大豆酪素消化液洋菜培養基,於30℃好氣條件下培養48小時後,確認其等之增殖性。
將其結果示於表6。
由表6之結果顯示,製造例2之杜鵑醇衍生物係較比較例1之杜鵑醇具有更低之MIC值,故為具有非常高抗菌活性之優越抗臭活性劑。
使用上述製造例1、製造例2所得之杜鵑醇衍生物及杜鵑醇(比較例1),進行下示之黑色素生成抑制試驗。
將B16黑瘤細胞以10vol%含小牛血清MEM培養基,於12孔培養盤依1×104
個/well進行播種,以常法培養24小時。前培養後,與添加了試料(製造例1及比較例1)的試驗培養基進行交換,進行培養72小時。作為試驗培養基,係使用於上述前培養用培養基中依成為2mmol/L之方式添加茶鹼者。培養後,使其溶解於含10vol%二甲基亞碸之1mol/L氫氧化鈉水溶液中,測定OD475值作為黑色素量。又,同時使用Coomasie Plus Protein Assay Reagent Kit(PIERCE公司製),將溶解液之總蛋白質量進行定量,算出每蛋白質量之黑色素量。
黑色素生成抑制率(%)=(A-B)/A×100
(其中,A:未添加試料時之每蛋白質量的黑色素量,B:試料添加時之每蛋白質量的黑色素量)
以橫軸為濃度、縱軸為黑色素生成抑制率進行繪圖作成圖表,由此圖表求取抑制50%黑色素生成的濃度(IC50
)。
將結果示於表7。
由表7之結果可知,本發明之杜鵑醇衍生物係較比較例1之杜鵑醇,顯示同等的黑色素生成抑制效果。
使用上述製造例1、2所得之杜鵑醇衍生物、與調配了杜鵑醇之皮膚乳膏,進行以下所示之美白實用試驗。
於被試驗者20名之前手腕屈側部皮膚上,曝曬夏季太陽光3小時(1天1.5小時,連續2天)。曝曬後對被試驗者之左前手腕屈側部皮膚,依1天早晚各1次、連續13周塗佈下述表8之實施例2及實施例3的皮膚乳膏。又,對被試驗者之右前手腕屈側部皮膚依同樣條件塗佈下表8之比較例6之皮膚乳膏。最終塗佈結束時,由專業評判員針對左右前手腕屈側部皮膚之連用前後之美白程度進行評價。又,評價係將確認到美白效果之被試驗者視為「具美白效果」,並表示其人數。
將結果示於下表9。由此結果可知,調配了本發明之杜鵑醇衍生物的皮膚乳膏,係相較於調配了比較例6之杜鵑醇的皮膚乳膏,更加提升對油劑的溶解性,故可作為非常優越的美白化妝料。又,試驗期間中,於實施例2及實施例3之塗佈了皮膚乳膏的部位,確認到皮膚刺激反應及皮膚感應反應的被試驗者並未出現,可確認到本發明物即使是製劑形態仍安全。
其次,使用製造例1~7之化合物,依下述調配成分,藉常法製造各化妝料。
(註10)蜂王漿(API公司製)
(註11)蘆薈萃取凝膠BG(丸善製藥公司製)
(註12)黃柏萃取液J(丸善製藥公司製)
可將本發明之杜鵑醇衍生物應用於實施例4~18之化妝料製劑,此外,藉由使用此等,可表現優越的美白作用、防腐抗菌作用、痤瘡預防‧改善作用及抗臭作用。
本發明之杜鵑醇衍生物係藉由提升溶解性,而可應用於廣泛的劑型,例如洗劑類、乳液類、乳膏類、面膜類、入浴劑等之化妝料。又,本發明之杜鵑醇衍生物由於具有優越的美白作用、防腐抗菌作用、痤瘡預防‧改善作用及抗臭作用,故藉由使用調配了本發明之杜鵑醇衍生物的皮膚外用劑,則於皮膚美容方面非常有用。
Claims (8)
- 一種皮膚外用劑,其含有下述一般式(1)所示之杜鵑醇(Rhododendrol)衍生物;
(式中,R1 表示碳數2~20之醯基,R2 表示氫原子或碳數2~20之醯基)。 - 一種美白化妝料,其含有下述一般式(1)所示之杜鵑醇衍生物;
(式中,R1 表示碳數2~20之醯基,R2 表示氫原子或碳數2~20之醯基)。 - 一種美白劑,其含有下述一般式(1)所示之杜鵑醇衍生物作為有效成分;
(式中,R1 表示碳數2~20之醯基,R2 表示氫原子或碳數2~20之醯基)。 - 一種防腐殺菌劑,其含有下述一般式(1a)所示之杜鵑醇 衍生物作為有效成分;
(式中,R1a 表示碳數2~4之醯基)。 - 一種痤瘡肌膚用皮膚外用劑,其含有下述一般式(1a)所示之杜鵑醇衍生物;
(式中,R1a 表示碳數2~4之醯基)。 - 一種抗臭用皮膚外用劑,其含有下述一般式(1a)所示之杜鵑醇衍生物;
(式中,R1a 表示碳數2~4之醯基)。 - 一種抗臭劑,其含有下述一般式(1a)所示之杜鵑醇衍生物作為有效成分;
(式中,R1a 表示碳數2~4之醯基)。 - 一種下述一般式(1b)所示之杜鵑醇衍生物;
(式中,R1b 及R2b 分別表示碳數3~20之醯基)。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008261138 | 2008-10-07 | ||
| JP2008261140 | 2008-10-07 | ||
| JP2008261137 | 2008-10-07 | ||
| JP2008284802 | 2008-11-05 | ||
| JP2008284801 | 2008-11-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201019968A TW201019968A (en) | 2010-06-01 |
| TWI400094B true TWI400094B (zh) | 2013-07-01 |
Family
ID=42100379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW098133946A TWI400094B (zh) | 2008-10-07 | 2009-10-07 | Skin external preparations |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPWO2010041417A1 (zh) |
| KR (1) | KR20110069040A (zh) |
| CN (1) | CN102164489A (zh) |
| TW (1) | TWI400094B (zh) |
| WO (1) | WO2010041417A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105017194B (zh) * | 2015-07-08 | 2018-05-22 | 渤海大学 | 含愈创兰烃薁结构的酪氨酸酶抑制剂及其制备方法与应用 |
| JP2019501221A (ja) * | 2015-12-30 | 2019-01-17 | アレクサンドル・ヴィレノヴィチ・アサフォフASAFOV, Alexander Vilenovich | 末梢関節、脊椎関節および/または結合組織の細胞外マトリックス構成要素の処置のための製剤、製造方法および使用 |
| FR3101544B1 (fr) * | 2019-10-07 | 2023-09-29 | Sederma Sa | Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères |
| CN116440038A (zh) * | 2023-04-27 | 2023-07-18 | 陕西慧康生物科技有限责任公司 | 具有“双面胶”式功效的防晒肽组合物及应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW464501B (en) * | 1996-12-17 | 2001-11-21 | Kanebo Ltd | Melanine formation inhibitor and their beautiful-white cosmetic |
| JP2008007432A (ja) * | 2006-06-27 | 2008-01-17 | Kao Corp | 皮膚外用剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3340928B2 (ja) * | 1996-12-24 | 2002-11-05 | カネボウ株式会社 | メラニン生成抑制剤および美白化粧料 |
| JP3340935B2 (ja) * | 1997-03-26 | 2002-11-05 | カネボウ株式会社 | メラニン生成抑制剤及び美白化粧料 |
| JP4871782B2 (ja) * | 2006-09-01 | 2012-02-08 | 花王株式会社 | 皮膚外用剤 |
-
2009
- 2009-10-06 KR KR1020117007481A patent/KR20110069040A/ko not_active Withdrawn
- 2009-10-06 CN CN2009801377144A patent/CN102164489A/zh active Pending
- 2009-10-06 JP JP2010532804A patent/JPWO2010041417A1/ja not_active Withdrawn
- 2009-10-06 WO PCT/JP2009/005170 patent/WO2010041417A1/ja not_active Ceased
- 2009-10-07 TW TW098133946A patent/TWI400094B/zh not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW464501B (en) * | 1996-12-17 | 2001-11-21 | Kanebo Ltd | Melanine formation inhibitor and their beautiful-white cosmetic |
| JP2008007432A (ja) * | 2006-06-27 | 2008-01-17 | Kao Corp | 皮膚外用剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20110069040A (ko) | 2011-06-22 |
| WO2010041417A1 (ja) | 2010-04-15 |
| JPWO2010041417A1 (ja) | 2012-03-01 |
| TW201019968A (en) | 2010-06-01 |
| CN102164489A (zh) | 2011-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2016210232A1 (en) | Niacinamide mononucleotide formulations for skin aging | |
| JP2012001467A (ja) | 皮膚外用剤 | |
| KR101851010B1 (ko) | 항염증 및 항균활성을 가지는 조성물 | |
| TWI400094B (zh) | Skin external preparations | |
| JP5514739B2 (ja) | メラニン生成抑制剤及び皮膚外用剤 | |
| JP2016150900A (ja) | メラニン産生抑制用の皮膚外用剤 | |
| JP2009196980A (ja) | メラニン生成抑制剤及び美白化粧料 | |
| JP5669436B2 (ja) | 組成物 | |
| JPWO2016121962A1 (ja) | メラニン産生抑制剤 | |
| US20060093689A1 (en) | Skin cosmetics | |
| JP2011241164A5 (zh) | ||
| JP2010100554A (ja) | メラニン生成抑制剤 | |
| KR100851044B1 (ko) | 미백효과를 나타내는 3,5-디히드록시 벤즈아미드 유도체,및 이를 함유하는 화장료 조성물 | |
| JP6616941B2 (ja) | 抗炎症剤及びメラニン生成抑制剤 | |
| KR102160306B1 (ko) | 피부미백제 | |
| JP2005170918A (ja) | 皮膚外用剤 | |
| JP5778134B2 (ja) | 皮膚外用剤 | |
| JP2013166731A (ja) | エンドセリン作用抑制剤及び美白剤 | |
| JP4658898B2 (ja) | メラニン生成抑制剤及び美白化粧料 | |
| JP2007269683A (ja) | 皮膚外用剤 | |
| JP2013032311A (ja) | エンドセリン作用抑制剤及び美白剤 | |
| JP2005247732A (ja) | 皮膚外用剤 | |
| JP2002145748A (ja) | 美白化粧料 | |
| JP2001335458A (ja) | 皮膚外用剤 | |
| TW201302233A (zh) | 黑色素生成抑制劑 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |